FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2397834905> ?p ?o ?g. }

• W2397834905 endingPage "80" @default.
• W2397834905 startingPage "172" @default.
• W2397834905 abstract "Prostate-specific antigen (PSA) screening is associated with a decline in prostate cancer-related mortality. However, screening has also led to overdiagnosis and overtreatment of clinically insignificant tumors. Recently, certain national guidelines (eg, US Preventive Services Task Force) have recommended against PSA screening, which may lead to a reverse-stage migration. Although many prostate tumors are indolent at presentation, others are aggressive and are appropriate targets for treatment interventions. Utilization of molecular markers may improve our ability to measure tumor biology and allow better discrimination of indolent and aggressive tumors at diagnosis. Many emerging commercial molecular diagnostic assays have been designed to provide more accurate risk stratification for newly diagnosed prostate cancer. Unfamiliarity with molecular diagnostics may make it challenging for some clinicians to navigate and interpret the medical literature to ascertain whether particular assays are appropriately developed and validated for clinical use. Herein, the authors provide a framework for practitioners to use when assessing new tissue-based molecular assays. This review outlines aspects of assay development, clinical and analytic validation and clinical utility studies, and regulatory issues, which collectively determine whether tests (1) are actionable for specific clinical indications, (2) measurably influence treatment decisions, and (3) are sufficiently validated to warrant incorporation into clinical practice." @default.
• W2397834905 created "2016-06-24" @default.
• W2397834905 creator A5007324727 @default.
• W2397834905 creator A5033253417 @default.
• W2397834905 creator A5058375967 @default.
• W2397834905 creator A5062834106 @default.
• W2397834905 creator A5072104844 @default.
• W2397834905 creator A5074513318 @default.
• W2397834905 date "2014-01-01" @default.
• W2397834905 modified "2023-09-27" @default.
• W2397834905 title "A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer." @default.
• W2397834905 cites W1551461559 @default.
• W2397834905 cites W1888052965 @default.
• W2397834905 cites W1975689368 @default.
• W2397834905 cites W1984982865 @default.
• W2397834905 cites W1998343146 @default.
• W2397834905 cites W1998817878 @default.
• W2397834905 cites W2000056288 @default.
• W2397834905 cites W2028643667 @default.
• W2397834905 cites W2043672855 @default.
• W2397834905 cites W2050619780 @default.
• W2397834905 cites W2061526396 @default.
• W2397834905 cites W2105882193 @default.
• W2397834905 cites W2108480019 @default.
• W2397834905 cites W2113499049 @default.
• W2397834905 cites W2115581335 @default.
• W2397834905 cites W2117692326 @default.
• W2397834905 cites W2129859749 @default.
• W2397834905 cites W2137053366 @default.
• W2397834905 cites W2148863957 @default.
• W2397834905 cites W2151494814 @default.
• W2397834905 cites W2151726995 @default.
• W2397834905 cites W2158099560 @default.
• W2397834905 cites W2160377567 @default.
• W2397834905 cites W2162127733 @default.
• W2397834905 cites W2164050696 @default.
• W2397834905 cites W2165983722 @default.
• W2397834905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4274174" @default.
• W2397834905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25548544" @default.
• W2397834905 hasPublicationYear "2014" @default.
• W2397834905 type Work @default.
• W2397834905 sameAs 2397834905 @default.
• W2397834905 citedByCount "11" @default.
• W2397834905 countsByYear W23978349052015 @default.
• W2397834905 countsByYear W23978349052016 @default.
• W2397834905 countsByYear W23978349052017 @default.
• W2397834905 countsByYear W23978349052018 @default.
• W2397834905 crossrefType "journal-article" @default.
• W2397834905 hasAuthorship W2397834905A5007324727 @default.
• W2397834905 hasAuthorship W2397834905A5033253417 @default.
• W2397834905 hasAuthorship W2397834905A5058375967 @default.
• W2397834905 hasAuthorship W2397834905A5062834106 @default.
• W2397834905 hasAuthorship W2397834905A5072104844 @default.
• W2397834905 hasAuthorship W2397834905A5074513318 @default.
• W2397834905 hasConcept C118552586 @default.
• W2397834905 hasConcept C121608353 @default.
• W2397834905 hasConcept C126322002 @default.
• W2397834905 hasConcept C142724271 @default.
• W2397834905 hasConcept C177713679 @default.
• W2397834905 hasConcept C179786068 @default.
• W2397834905 hasConcept C19527891 @default.
• W2397834905 hasConcept C27415008 @default.
• W2397834905 hasConcept C2775941076 @default.
• W2397834905 hasConcept C2779377019 @default.
• W2397834905 hasConcept C2779974597 @default.
• W2397834905 hasConcept C2780192828 @default.
• W2397834905 hasConcept C2781406297 @default.
• W2397834905 hasConcept C3020404979 @default.
• W2397834905 hasConcept C512399662 @default.
• W2397834905 hasConcept C60644358 @default.
• W2397834905 hasConcept C71924100 @default.
• W2397834905 hasConcept C86803240 @default.
• W2397834905 hasConceptScore W2397834905C118552586 @default.
• W2397834905 hasConceptScore W2397834905C121608353 @default.
• W2397834905 hasConceptScore W2397834905C126322002 @default.
• W2397834905 hasConceptScore W2397834905C142724271 @default.
• W2397834905 hasConceptScore W2397834905C177713679 @default.
• W2397834905 hasConceptScore W2397834905C179786068 @default.
• W2397834905 hasConceptScore W2397834905C19527891 @default.
• W2397834905 hasConceptScore W2397834905C27415008 @default.
• W2397834905 hasConceptScore W2397834905C2775941076 @default.
• W2397834905 hasConceptScore W2397834905C2779377019 @default.
• W2397834905 hasConceptScore W2397834905C2779974597 @default.
• W2397834905 hasConceptScore W2397834905C2780192828 @default.
• W2397834905 hasConceptScore W2397834905C2781406297 @default.
• W2397834905 hasConceptScore W2397834905C3020404979 @default.
• W2397834905 hasConceptScore W2397834905C512399662 @default.
• W2397834905 hasConceptScore W2397834905C60644358 @default.
• W2397834905 hasConceptScore W2397834905C71924100 @default.
• W2397834905 hasConceptScore W2397834905C86803240 @default.
• W2397834905 hasIssue "4" @default.
• W2397834905 hasLocation W23978349051 @default.
• W2397834905 hasOpenAccess W2397834905 @default.
• W2397834905 hasPrimaryLocation W23978349051 @default.
• W2397834905 hasRelatedWork W103670294 @default.
• W2397834905 hasRelatedWork W2054574634 @default.
• W2397834905 hasRelatedWork W2168939427 @default.
• W2397834905 hasRelatedWork W2397834905 @default.

• next